(Q38073178)

28 August 2017

1 reference

title

MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas (English)

1 reference

28 August 2017

8

Marian Hajduch

1 reference

28 August 2017

Vladimir Balik

1

1 reference

28 August 2017

Josef Srovnal

2

1 reference

28 August 2017

Igor Sulla

3

1 reference

28 August 2017

Ondrej Kalita

4

1 reference

28 August 2017

Tatiana Foltanova

5

1 reference

28 August 2017

Miroslav Vaverka

6

1 reference

28 August 2017

Lumir Hrabalek

7

1 reference

28 August 2017

publication date

11 January 2013

1 reference

Journal of Neuro-Oncology

28 August 2017

published in

1 reference

28 August 2017

volume

112

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

1-8

1 reference

The 2007 WHO classification of tumours of the central nervous system

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Meningioma: analysis of recurrence and progression following neurosurgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Small regulatory RNAs in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The p53-Mdm2 module and the ubiquitin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Activation of p53 by MEG3 non-coding RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Amplification of a gene encoding a p53-associated protein in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Tumor suppression and normal aging in mice with constitutively high p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Alternative and aberrant splicing of MDM2 mRNA in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The expanding role of cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

RB and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Increased expression of angiogenic genes in the brains of mouse meg3-null embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Human-ovine comparative sequencing of a 250-kb imprinted domain encompassing the callipyge (clpg) locus and identification of six imprinted transcripts: DLK1, DAT, GTL2, PEG11, antiPEG11, and MEG8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Insights from gene arrays on the development and growth regulation of uterine leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Radiation-induced epigenetic alterations after low and high LET irradiations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-1038-6

Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Inactivation of imprinted genes induced by cellular stress and tumorigenesis

1 reference

12 December 2020

Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.

1 reference

12 December 2020

Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression

1 reference

12 December 2020

The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival

1 reference

12 December 2020

MEG3 imprinted gene contribution in tumorigenesis

1 reference

12 December 2020

Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus

1 reference

12 December 2020

The RING domain of Mdm2 can inhibit cell proliferation

1 reference

12 December 2020

Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas

1 reference

12 December 2020

Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

1 reference

12 December 2020

Recurrence of meningiomas

1 reference

12 December 2020

Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression

1 reference

12 December 2020

An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2

1 reference

12 December 2020

Tumor promotion by Mdm2 splice variants unable to bind p53.

1 reference

12 December 2020

10.1007/S11060-012-1038-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1033387693

0 references

1 reference